Journal of Pharmaceutical and Biomedical Sciences

Login
Select Language
Subscription Login to verify subscription
Give a gift subscription
Article Tools
Print this article
Indexing metadata
How to cite item
Finding References
Review policy
Email this article (Login required)
Email the author(Login required)
Post a Comment (Login required)

Oral Misoprostol versus Intravenous Methylergometrine for the Prevention of Postpartum Haemorrhage

Sipra Lenka, Amit Agrawal, Pratima Mishra

Abstract


Background Post partum haemorrhage is one of the most common causes of maternal mortality. Uterine atonicity, trauma to the genital tract, retained product of placenta are common causes of postpartum haemorrhage (PPH), out of these, atonicity contributes to a majority of cases. Many drugs have been used for the contraction of the uterus such as oxytocin, misoprostol and methylergometrine. In this study, the role of IV methylergometrine was compared with oral misoprostol for the prevention of PPH.

Materials and Methods Study of 180 women who received IV methylergometrine or oral misoprostol 600 mcg to prevent post PPH was carried out in the labour room of Hi-Tech Medical College and Hospitals, Bhubaneswar, Odisha, India, between January 2014 and January 2015.

Result and conclusion: In this study oral misoprostol was found to be safe, non invasive and effective method in prevention of PPH specially in low resource setting in India.


Keywords


postpartum haemorrhage, misoprostol, methylergometrine

Full Text:

References


Ramanathan G, Arulkumaran S. Postpartum haemorrhage. Curr Obstet Gynaecol. 2006;16(1):6–13.

Kane TT, el-Kady AA, Saleh S, Hage M, Stanback J, Potter L. Maternal mortality in Giza, Egypt: magnitude, causes, and prevention. Stud Fam Plann. 1992;23:45–57.

Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev. 2000;3:CD000007.

Potts M, Prata N, Walsh J, Grossman A. Parachute approach to evidence based medicine. BMJ. 2006;333:701–703.

Hogerzeil HV, Walker GJ. Instability of (methyl) ergometrine in tropical climates: an overview. Eur J Obstet Gynecol Reprod Biol.1996;69:25–29.

Hofmeyr GJ, Walraven G, Gülmezoglu AM, Maholwana B, Alfirevic Z, Villar J. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG. 2005;112:547–553.

Sanghvi H. Prevention of postpartum hemorrhage study, West Java, Indonesia. 2004.

Mousa HA, Alfirevic Z. Treatment for primary postpartum hemorrhage. Cochrane Database Syst Rev. 2007;1:CD003249.

Caliskan E, Dilbaz B, Meydanli MM, Oztürk N, Narin MA, Haberal A. Oral misoprostol for the third stage of labor: a randomized controlled trial. Obstet Gynecol. 2003;101:921–928.

Lalonde A, Daviss BA, Acosta A, Herschderfer K. Postpartum hemorrhage today: ICM/FIGO initiative 2004-2006. Int J Gynecol Obstet. 2006;94:243–53.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.